Clarion Partners Named 2023 Best in Building Health Award Winner By Fitwel

Press Release

Fitwel 2023 Best In Building Health Award Winner: Clarion Partners

​​​​​​​​​​​​NEW YORK – March 23, 2023 – Today, Fitwel announced that Clarion Partners has been named Best in Building Health (BiBH) with the Industry Leadership Award for Portfolio Benchmarking.* Best in Building Health honors best-in-class real estate companies and individuals who are leading the healthy building movement by example, leveraging Fitwel's data-driven, scalable technology platform to set the bar for excellence in building health.

Created in partnership with the U.S. Centers for Disease Control and Prevention (CDC) and operated by nonprofit research organization, Center for Active Design (CfAD), Fitwel is a people-centric healthy building certification system that sets the industry standard for evidence-based strategies to promote health and wellness through the built environment. Fitwel's data-driven platform integrates asset and portfolio-level benchmarking, a streamlined healthy building certification process, and “S" focused ESG reporting guidance.

Clarion Partners joined the Fitwel Champion network in 2020 and the firm has 21 active Fitwel certifications, with additional certifications and recertifications expected in the future.** Clarion also participates in the Fitwel Leadership Advisory Board, which offers organizations the opportunity to actively participate in maintaining Fitwel's vision by providing direction and input into its continuous growth.

“Clarion Partners is honored to be recognized by Fitwel. As a firm, we seek to add value to our assets through a variety of initiatives including well-being and sustainability," said Karen Mahrous, Head of ESG at Clarion Partners. “Fitwel provides accountability and data insights through their benchmarking platform which we look forward to leveraging to enhance asset value."

“The past few years have been transformational, revealing unprecedented challenges and opportunities for the world, and in particular, the real estate industry and healthy building movement," said Joanna Frank, President and CEO of CfAD. “As Clarion Partners' achievements have demonstrated, prioritizing health is no longer a reactive market trend – it's an established business imperative that represents an opportunity for real estate to mitigate risk and maximize investment."

Kicking off today with the announcement of Best in Building Health winners, the 2023 BiBH celebration will continue throughout the year as Fitwel continues to amplify its winners' achievements on digital and print mediums. This year, Fitwel will launch its inaugural issue of Building Health, a print publication that will include feature stories about BiBH winners, as well as deliver meaningful industry insights and trends into the healthy building movement, analyzing its evolution and substantiating the value and impact of health-centric “S" strategies in ESG reporting. 

To view the complete list of BiBH winners, visit this link:

* Best in Building Health Awards are issued by The Center for Active Design (CfAD) annually; categories vary annually. Clarion Partners received the Industry Leadership Award for Portfolio Benchmarking on March 23, 2023. Clarion did not apply to pursue this award, but fees were paid in conjunction with the portfolio benchmarking program.

​** Certifications are issued on a rolling basis by The Center for Active Design (CfAD) and are valid for three years. Properties must re-certify to maintain certification standing. These 21 Clarion properties held valid certifications as of January 30, 2023. Rankings range from One to Three Stars for individual properties. Properties must pay certification fees to pursue Fitwel certifications.





Get in touch

We're here to answer your questions.

Contact us

Our offices

  • New York (HQ)
  • Boston
  • Dallas
  • Los Angeles
  • Washington D.C.
  • London
  • Frankfurt
  • Jersey
  • Madrid
  • Paris

Investment in real estate is speculative and involves significant risk. For more information about certain of the material risks and limitations associated with Clarion Partners’ investment advisory products, strategies and services, please see Clarion’s current Form ADV Part 2A brochure, which is available on the SEC’s Investment Adviser Public Disclosure website at Investors should consider their investment objectives, and it is strongly suggested that the reader seek his or her own independent advice in relation to any investment, financial, legal, tax, accounting or regulatory risks and evaluate their own risk tolerance before investing.

This material does not constitute investment advice, nor does it constitute an offer in any product or strategy offered by Clarion Partners LLC or Clarion Partners Europe, and should not be viewed as a current or past recommendation to buy or sell any securities. Any specific investment referenced may or may not be held in a Clarion Partners client account. It should not be assumed that any investment, in any property or other asset, was or will be profitable.

All Clarion Partners LLC and Clarion Partners Europe statistics, data and charts, including but not limited to assets under management (AUM), ESG data, sector data and property data, as well as data related to our investors, tenants and employees, are as of December 31, 2023 unless otherwise noted.

Photos used in this website were selected based on visual appearance, are used for illustrative purposes only, and are not necessarily reflective of all the investments in a Clarion fund or portfolio or the investments a Clarion fund or portfolio will make in the future.


You are leaving and being directed to a new site.

You have selected a link that will take you away from the Clarion Partners website. Although we have verified the accuracy of this link from our website to a third party website, the content of the web pages may change without notice. We are not responsible for the content, views, or privacy policies of the third party website. Privacy and security policies of such site may differ from those practiced by Clarion Partners.

By clicking on the ACCEPT button below, you acknowledge the previous statement and will be taken to the linked site. If you want to remain at this site, select the DECLINE button.

Decline Accept